The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, randomized, double-blind, placebo-controlled study of enzalutamide in men with nonmetastatic castration-resistant prostate cancer: Post-hoc analysis of PROSPER by prior therapy.
 
Ugo De Giorgi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Pfizer; Sanofi
 
Eleni Efstathiou
Honoraria - Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Innocrin Pharma; Janssen-Cilag; MSD; Sanofi; Takeda; Tolmar
Speakers' Bureau - Janssen-Cilag
Research Funding - Astellas Pharma; Janssen-Cilag; Sanofi
 
William R. Berry
No Relationships to Disclose
 
Heather Ann Payne
Honoraria - Astellas Pharma; AstraZeneca; FERRING; Janssen-Cilag; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen-Cilag
Speakers' Bureau - Janssen-Cilag
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Katarzyna Madziarska
No Relationships to Disclose
 
Katharina Modelska
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Xiaowei Guan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jennifer Sugg
Employment - Astellas Pharma
Stock and Other Ownership Interests - AstraZeneca
 
Joyce Leta Steinberg
Employment - Astellas Pharma
Stock and Other Ownership Interests - Amgen (I)
Travel, Accommodations, Expenses - Astellas Pharma
 
Cora N. Sternberg
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Incyte; Ipsen; MSD; Novartis; Pfizer; Roche; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Aveo (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Genzyme (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Myovant Sciences (Inst); Nektar (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)